News | March 13, 2021
Altimmune expands AdCOVID manufacturing collaboration with Lonza
AdCOVID is a COVID-19 vaccine candidate that is administered via nasal spray.
AdCOVID is a COVID-19 vaccine candidate that is administered via nasal spray.
Lonza maintained business continuity during the COVID-19 pandemic with minimal impacts to operations and supply throughout 2020.
Usage of Synaffix GlycoConnect, HydraSpace and toxSYN ADC technologies to enhance efficacy, tolerability and target engagement
Abdel has held leadership positions at Bayer, Merck, Catalent, Lonza, and KBI Biopharma,
New Board of Directors and management team at Suven Pharma also appointed
40,000 visitors and representatives of more than 80 countries set to visit the show
Dr. Mahdavi will lead Ginkgo's commercial efforts in the growing areas of bio-reagents, cell and gene therapies and new biopharmaceutical modalities.
_256_384.jpg){kind=logo}
Meets the growing need for US-based API solubility and bioavailability enhancement services
Brings 25 years of global operations and supply chain experience to Piramal
Purpose-built bioconjugation facility in Lonza’s Ibex Dedicate Biopark in Visp, Switzerland to support the potential commercial launch of Kodiak's lead product candidate KSI-301 for high-prevalence retinal diseases
Subscribe To Our Newsletter & Stay Updated
